With a focus on complex chemistry and niche therapy areas, Biophore has built a unique portfolio around Oncology, Contrast Media, Colored APIs, Peptides, Hormonals, Iron products, Injectable APIs etc.
We currently have 110+ US DMFs and 20+ CEPs along with regulatory filings across Canada, China, Korea, MENA and other global markets
At any point in time, our research team is working on 20+ development projects with an objective to deliver robust and quality products to the market in the shortest possible time
Please visit our Portfolio page for our entire product list